Interesting question.Traditionally, in Rad Onc, post operative RT after bone stabilization has been given to patients whom the operating surgeons deemed "appropriate". Some literature suggest only 28% to 50% of post-op patients are referred for post op EBRT.As such, because the data are so 'sketchy'...

In terms of field coverage, as a resident, I always referred to my then brand new 7th edition of DeVita's Cancer--Principles & Practice of Oncology (2005, Lippincott Williams & Wilkins), Chapter 51.4 Treatment of Metastatic Cancer (Mark W. Manoso and John H. Healey), p 2379: "No matter what...

I have appreciated the comments on this thread, especially from those with many years of experience. On the question of volumes, I wonder what the added value of large margins is, outside of a possible oligometastatic setting. If the patient has numerous bone metastases, we are presumably only treat...

My approach is similar to Dan's. We considered a protocol for single fraction treatment in the postoperative setting but there were not enough patients. It is practically a good solution for some patients depending on PS.This is a decent paper that evaluated recurrence by extent of hardware coverage...

I am unaware of any clear data to guide us on whether to treat just the area of the lesion or the entire stabilization rod. Like a lot of things in medicine, we can be influenced by a particularly memorable case. As a resident, I had a 70ish woman, newly diagnosed with metastatic lung cancer and a ...

I agree the true value of postoperative RT is uncertain. However, the group from Brigham and Women's Hospital/Dana-Farber Cancer Institute published an analysis of their experience showing that 29% of the 17% of patients having local progression developed it marginally or out of field, but adjacent ...